Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Hereditary Angioedema Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Shire plc
Adverum
BIOCRYST PHARMACEUTICALS,INC
CSL Behring
Pharming Group NV
lonis Pharmaceuticals,Inc
Arrowhead Pharmaceuticals,Inc
By Type:
C-1 Esterase Inhibitors
Kallikrein Inhibitors
Bradykynin Receptor Antagonist
By Application:
Treatment
Prophylaxis
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Hereditary Angioedema Treatment Market Overview 2018-2029
-
1.1 China Hereditary Angioedema Treatment Industry Development Overview
-
1.2 China Hereditary Angioedema Treatment Industry Development History
-
1.3 China Hereditary Angioedema Treatment Industry Market Size (2018-2029)
-
1.4 China Hereditary Angioedema Treatment Market Analysis by Type from Production Side
-
1.4.1 China Hereditary Angioedema Treatment Production Volume, Production Value and Growth Rate of C-1 Esterase Inhibitors (2018-2029)
-
1.4.2 China Hereditary Angioedema Treatment Production Volume, Production Value and Growth Rate of Kallikrein Inhibitors (2018-2029)
-
1.4.3 China Hereditary Angioedema Treatment Production Volume, Production Value and Growth Rate of Bradykynin Receptor Antagonist (2018-2029)
-
1.5 China Hereditary Angioedema Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Hereditary Angioedema Treatment Sales Volume, Sales Value and Growth Rate of Treatment (2018-2029)
-
1.5.2 China Hereditary Angioedema Treatment Sales Volume, Sales Value and Growth Rate of Prophylaxis (2018-2029)
-
1.6 China Hereditary Angioedema Treatment Market Analysis by Region
-
1.6.1 North China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Hereditary Angioedema Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Hereditary Angioedema Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Hereditary Angioedema Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Hereditary Angioedema Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Hereditary Angioedema Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Hereditary Angioedema Treatment Industry Development
Chapter 3 Hereditary Angioedema TreatmentIndustry Chain Analysis
-
3.1 Hereditary Angioedema Treatment Industry Chain
-
3.2 Hereditary Angioedema Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Hereditary Angioedema Treatment Market
-
3.3 Hereditary Angioedema Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Hereditary Angioedema Treatment Market
Chapter 4 China Hereditary Angioedema Treatment Market, by Type
-
4.1 China Hereditary Angioedema Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Hereditary Angioedema Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Hereditary Angioedema Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Hereditary Angioedema Treatment Production Volume and Growth Rate of C-1 Esterase Inhibitors
-
4.5.2 China Hereditary Angioedema Treatment Production Volume and Growth Rate of Kallikrein Inhibitors
-
4.5.3 China Hereditary Angioedema Treatment Production Volume and Growth Rate of Bradykynin Receptor Antagonist
Chapter 5 China Hereditary Angioedema Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Hereditary Angioedema Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Hereditary Angioedema Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Hereditary Angioedema Treatment Market Size and Growth Rate of Treatment
-
5.5.2 China Hereditary Angioedema Treatment Market Size and Growth Rate of Prophylaxis
Chapter 6 China Hereditary Angioedema Treatment Market, by Region
-
6.1 China Hereditary Angioedema Treatment Production Volume and Production Value, by Region
-
6.2 China Hereditary Angioedema Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Hereditary Angioedema Treatment Market Analysis
-
7.1 North China Hereditary Angioedema Treatment Market, by Type
-
7.2 North China Hereditary Angioedema Treatment Market, by Application
Chapter 8 Central China Hereditary Angioedema Treatment Market Analysis
-
8.1 Central China Hereditary Angioedema Treatment Market, by Type
-
8.2 Central China Hereditary Angioedema Treatment Market, by Application
Chapter 9 South China Hereditary Angioedema Treatment Market Analysis
-
9.1 South China Hereditary Angioedema Treatment Market, by Type
-
9.2 South China Hereditary Angioedema Treatment Market, by Application
Chapter 10 East China Hereditary Angioedema Treatment Market Analysis
-
10.1 East China Hereditary Angioedema Treatment Market, by Type
-
10.2 East China Hereditary Angioedema Treatment Market, by Application
Chapter 11 Northeast China Hereditary Angioedema Treatment Market Analysis
-
11.1 Northeast China Hereditary Angioedema Treatment Market, by Type
-
11.2 Northeast China Hereditary Angioedema Treatment Market, by Application
Chapter 12 Southwest China Hereditary Angioedema Treatment Market Analysis
-
12.1 Southwest China Hereditary Angioedema Treatment Market, by Type
-
12.2 Southwest China Hereditary Angioedema Treatment Market, by Application
Chapter 13 Northwest China Hereditary Angioedema Treatment Market Analysis
-
13.1 Northwest China Hereditary Angioedema Treatment Market, by Type
-
13.2 Northwest China Hereditary Angioedema Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 Shire plc
-
14.1.1 Shire plc Company Profile
-
14.1.2 Shire plc Hereditary Angioedema Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Adverum
-
14.2.1 Adverum Company Profile
-
14.2.2 Adverum Hereditary Angioedema Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 BIOCRYST PHARMACEUTICALS,INC
-
14.3.1 BIOCRYST PHARMACEUTICALS,INC Company Profile
-
14.3.2 BIOCRYST PHARMACEUTICALS,INC Hereditary Angioedema Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 CSL Behring
-
14.4.1 CSL Behring Company Profile
-
14.4.2 CSL Behring Hereditary Angioedema Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Pharming Group NV
-
14.5.1 Pharming Group NV Company Profile
-
14.5.2 Pharming Group NV Hereditary Angioedema Treatment Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 lonis Pharmaceuticals,Inc
-
14.6.1 lonis Pharmaceuticals,Inc Company Profile
-
14.6.2 lonis Pharmaceuticals,Inc Hereditary Angioedema Treatment Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Arrowhead Pharmaceuticals,Inc
-
14.7.1 Arrowhead Pharmaceuticals,Inc Company Profile
-
14.7.2 Arrowhead Pharmaceuticals,Inc Hereditary Angioedema Treatment Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Hereditary Angioedema Treatment Industry Research Conclusions
-
15.2 Hereditary Angioedema Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Hereditary Angioedema Treatment Industry Market Size (2018-2029)
-
Figure China Hereditary Angioedema Treatment Production Volume, Production Value and Growth Rate of C-1 Esterase Inhibitors (2018-2029)
-
Figure China Hereditary Angioedema Treatment Production Volume, Production Value and Growth Rate of Kallikrein Inhibitors (2018-2029)
-
Figure China Hereditary Angioedema Treatment Production Volume, Production Value and Growth Rate of Bradykynin Receptor Antagonist (2018-2029)
-
Figure China Hereditary Angioedema Treatment Sales Volume, Sales Value and Growth Rate of Treatment (2018-2029)
-
Figure China Hereditary Angioedema Treatment Sales Volume, Sales Value and Growth Rate of Prophylaxis (2018-2029)
-
Figure North China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Hereditary Angioedema Treatment Market Size and Growth Rate from 2018-2029
-
Figure Hereditary Angioedema Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Hereditary Angioedema Treatment Market Share by Type in 2018
-
Figure China Hereditary Angioedema Treatment Market Share by Type in 2023
-
Figure China Hereditary Angioedema Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Hereditary Angioedema Treatment Production Volume and Growth Rate of C-1 Esterase Inhibitors (2018-2023)
-
Figure China Hereditary Angioedema Treatment Production Volume and Growth Rate of Kallikrein Inhibitors (2018-2023)
-
Figure China Hereditary Angioedema Treatment Production Volume and Growth Rate of Bradykynin Receptor Antagonist (2018-2023)
-
Figure China Hereditary Angioedema Treatment Market Share by Application in 2018
-
Figure China Hereditary Angioedema Treatment Market Share by Application in 2023
-
Figure China Hereditary Angioedema Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Hereditary Angioedema Treatment Market Size and Growth Rate of Treatment (2018-2023)
-
Figure China Hereditary Angioedema Treatment Market Size and Growth Rate of Prophylaxis (2018-2023)
-
Table China Hereditary Angioedema Treatment Production Volume by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Production Volume Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Treatment Production Volume Share by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Production Value by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Production Value Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Treatment Production Value Share by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Sales Volume by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Treatment Sales Volume Share by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Sales Value by Region (2018-2023)
-
Table China Hereditary Angioedema Treatment Sales Value Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Treatment Sales Value Share by Region (2018-2023)
-
Table North China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table North China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table North China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table North China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table Central China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table Central China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table South China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table South China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table South China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table East China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table East China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table East China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Hereditary Angioedema Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Hereditary Angioedema Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Hereditary Angioedema Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Hereditary Angioedema Treatment Sales Volume Share by Application (2018-2023)
-
Table Shire plc Company Profile
-
Table Shire plc Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
Table Adverum Company Profile
-
Table Adverum Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
Table BIOCRYST PHARMACEUTICALS,INC Company Profile
-
Table BIOCRYST PHARMACEUTICALS,INC Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
Table CSL Behring Company Profile
-
Table CSL Behring Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
Table Pharming Group NV Company Profile
-
Table Pharming Group NV Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
Table lonis Pharmaceuticals,Inc Company Profile
-
Table lonis Pharmaceuticals,Inc Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
Table Arrowhead Pharmaceuticals,Inc Company Profile
-
Table Arrowhead Pharmaceuticals,Inc Hereditary Angioedema Treatment Revenue, Price and Gross (2018-2023)
-
